• The drug has long been linked to heart attacks. The Senate Finance Committee released a report over the weekend containing internal FDA documents recommending it should be pulled from the market. Glaxo, though, is trying its hardest to avoid the pulling of the diabetes drug, and is in the midst of a blind test with another drug, Actos, to show how safe it is. That’s despite the use of a fear-of-God “black box” warning on the drug, and despite a study noting a 43 percent increase in heart trouble for Avendia users. The report suggests Glaxo knew the issues but kept the drug on the market anyway. Yikes. source

Posted by Ernie Smith • Permalink